1. Home
  2. PROK vs MTW Comparison

PROK vs MTW Comparison

Compare PROK & MTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • MTW
  • Stock Information
  • Founded
  • PROK 2015
  • MTW 1902
  • Country
  • PROK United States
  • MTW United States
  • Employees
  • PROK N/A
  • MTW N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • MTW Construction/Ag Equipment/Trucks
  • Sector
  • PROK Health Care
  • MTW Industrials
  • Exchange
  • PROK Nasdaq
  • MTW Nasdaq
  • Market Cap
  • PROK 417.1M
  • MTW 354.6M
  • IPO Year
  • PROK N/A
  • MTW N/A
  • Fundamental
  • Price
  • PROK $2.97
  • MTW $10.83
  • Analyst Decision
  • PROK Strong Buy
  • MTW Hold
  • Analyst Count
  • PROK 4
  • MTW 4
  • Target Price
  • PROK $6.25
  • MTW $11.00
  • AVG Volume (30 Days)
  • PROK 2.1M
  • MTW 214.1K
  • Earning Date
  • PROK 11-11-2025
  • MTW 10-30-2025
  • Dividend Yield
  • PROK N/A
  • MTW N/A
  • EPS Growth
  • PROK N/A
  • MTW 436.41
  • EPS
  • PROK N/A
  • MTW 1.26
  • Revenue
  • PROK $527,000.00
  • MTW $2,131,200,000.00
  • Revenue This Year
  • PROK $427.89
  • MTW $0.28
  • Revenue Next Year
  • PROK N/A
  • MTW $4.99
  • P/E Ratio
  • PROK N/A
  • MTW $8.64
  • Revenue Growth
  • PROK N/A
  • MTW N/A
  • 52 Week Low
  • PROK $0.46
  • MTW $7.06
  • 52 Week High
  • PROK $7.13
  • MTW $13.62
  • Technical
  • Relative Strength Index (RSI)
  • PROK 55.05
  • MTW 58.94
  • Support Level
  • PROK $2.80
  • MTW $9.99
  • Resistance Level
  • PROK $3.28
  • MTW $11.00
  • Average True Range (ATR)
  • PROK 0.27
  • MTW 0.36
  • MACD
  • PROK 0.01
  • MTW 0.08
  • Stochastic Oscillator
  • PROK 57.52
  • MTW 78.57

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About MTW Manitowoc Company Inc. (The)

Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.

Share on Social Networks: